Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Takeda, Eisai, Daiichi Plead Guilty In Criminal "Vitamin Cartel" Case

This article was originally published in The Tan Sheet

Executive Summary

Three Japanese vitamin manufacturers have agreed to plead guilty to charges associated with "a worldwide conspiracy to raise and fix prices and allocate market shares for certain vitamins sold in the U.S. and elsewhere," the Department of Justice announced Sept. 9.
Advertisement

Related Content

Vitamin price fixing
Vitamin price fixing
Vitamin price fixing
BASF Global Vitamin Presence Strengthened With Takeda Combination
BASF and Takeda Chemical Industries
P&G Brings Price-Fixing Suit Against Vitamin Manufacturers
Vitamin Manufacturers Receive Canada's "Largest Criminal Fines" Ever
CFSAN Visiting Supplement Companies For Information On Developing GMPs
Wright Enrichment Lawsuit Seeks Class Action Against Vitamin Price Fixing
Wright Enrichment Lawsuit Seeks Class Action Against Vitamin Price Fixing

Topics

Advertisement
UsernamePublicRestriction

Register

PS090320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel